Stockreport
Is Gilead Sciences (GILD) Pricing Reflecting Recent 38.5% One Year Share Return? [Yahoo! Finance]
Last gilead sciences, inc. earnings: 4/30 04:01 pm
Check Earnings Report
US:NASDAQ Investor Relations: investors.gilead.com
The share price recently closed at US$121.10, with returns of 0.6% over 30 days and 38.5% over 1 year. This may change how investors think about both upside and risk. Recent attention on Gilead has focused on its position in pharmaceuticals and biotech, as investors reassess major sector names in light of product pipelines, drug approvals, and competitive pressures. This context helps explain why the stock's 56.0% 3 year and 131.7% 5 year returns might be on investors' radar when they look at the current price. On our valuation checks, Gilead Sciences currently scores 5 out of 6 . Next we will walk through what different valuation methods say about that score and point to a more complete way of thinking about value at the end of the article. Gilead Sciences delivered 38.5% returns over the last year. See how this stacks up to the rest of the Biotechs industry. A Discounted Cash Flow, or DCF, model projects a company's future cash flows and then discounts them back to today's
[Read more]
| IMPACT SNAPSHOT | EVENT TIME: | GILD | ||||
|---|---|---|---|---|---|---|
|
Last Price
|
Price Change
|
Price Change %
|
Volume Shares
|
Max Up
|
Max Down
|
Volume Ratio
%
|
Performance comparison
Updated
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| LAST PRICE | ||
| VWAP | ||
|
High:
|
MAX UP |
High:
|
|
Low:
|
MAX DOWN |
Low:
|
|
%
|
POST NEWS RANGE |
%
|
|
|
PRICE CHANGE |
|
|
|
PRICE CHANGE PERCENTAGE |
|
|
|
S&P 500 (SPX) |
|
|
%
|
VOLUME RATIO |
%
|
| VOLUME (SHARES) | ||
| TICKS | ||
|
|
AVG SHARES PER TRADE |
|
Don't Miss Out On The Next BIG Stock Move
EVENT DAY
Event Day Chart will not be displayed beyond 90-day period of the event
PERFORMANCE SINCE EVENT
TIME AND VELOCITY ANALYSIS
Be the first to know
Opt in for alerts from News Quantifed
Opt-in for
GILD alerts
GILD alerts
from News Quantified
Movers & Shakers
The biggest gainers and losers and WHY it moved
GILD alerts
High impacting Gilead Sciences, Inc. news events
Weekly update
A roundup of the hottest topics
GILD
NEWS
NEWS
- Gilead Sciences: From All-Time Highs To Higher Highs [Seeking Alpha][Seeking Alpha]
- UBS and Citi Go Bullish on Gilead Sciences (GILD) [Yahoo! Finance][Yahoo! Finance]
- The Bull Case For Gilead Sciences (GILD) Could Change Following New OncoNano Drug-Delivery Collaboration [Yahoo! Finance][Yahoo! Finance]
- Gilead price target raised to $154 from $144 at BofA [Yahoo! Finance][Yahoo! Finance]
- J&J cuts MFN deal with the Trump administration, bolsters US onshoring efforts [Yahoo! Finance][Yahoo! Finance]
- More
GILD
SEC Filings
SEC Filings
- 1/5/26 - Form 4
- 12/30/25 - Form 4
- 12/29/25 - Form 144
- GILD's page on the SEC website
- More